Page last updated: 2024-08-17

apomorphine and Brain Damage, Chronic

apomorphine has been researched along with Brain Damage, Chronic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Canteras, NS; Da Cunha, C; Ferro, MM; HipĆ³lide, D; Martinez, GR; Tufik, S; Vital, MA; Wietzikoski, EC1
Cozzari, C; Faris, PL; Hartman, BK; Jansen, EM; Low, WC; Solberg, L; Underhill, S; Wilson, S1
Goto, S; Okamura, A; Ushio, Y; Yamada, K; Yoshikawa, M1
Albanese, A; Moro, E1
Court, J; Godoy, J; Valenzuela, R1

Reviews

1 review(s) available for apomorphine and Brain Damage, Chronic

ArticleYear
Apomorphine and levodopa challenge in patients with a focal midbrain lesion.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:2

    Topics: Adult; Antiparkinson Agents; Apomorphine; Brain Damage, Chronic; Female; Humans; Levodopa; Male; Mesencephalon; Middle Aged; Parkinson Disease, Secondary; Treatment Outcome

1999

Trials

1 trial(s) available for apomorphine and Brain Damage, Chronic

ArticleYear
Apomorphine and levodopa challenge in patients with a focal midbrain lesion.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:2

    Topics: Adult; Antiparkinson Agents; Apomorphine; Brain Damage, Chronic; Female; Humans; Levodopa; Male; Mesencephalon; Middle Aged; Parkinson Disease, Secondary; Treatment Outcome

1999

Other Studies

4 other study(ies) available for apomorphine and Brain Damage, Chronic

ArticleYear
Hemiparkinsonian rats rotate toward the side with the weaker dopaminergic neurotransmission.
    Behavioural brain research, 2008, Jun-03, Volume: 189, Issue:2

    Topics: Analysis of Variance; Animals; Apomorphine; Brain Damage, Chronic; Disease Models, Animal; Dopamine; Dopamine Agonists; Functional Laterality; Locomotion; Male; Motor Activity; MPTP Poisoning; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Rotation; Severity of Illness Index; Statistics, Nonparametric; Substantia Nigra

2008
Transplantation of fetal neocortex ameliorates sensorimotor and locomotor deficits following neonatal ischemic-hypoxic brain injury in rats.
    Experimental neurology, 1997, Volume: 147, Issue:2

    Topics: Animals; Animals, Newborn; Apomorphine; Brain Damage, Chronic; Brain Ischemia; Brain Tissue Transplantation; Fetal Hypoxia; Fetal Tissue Transplantation; Hypoxia, Brain; Movement Disorders; Neocortex; Nerve Degeneration; Psychomotor Performance; Rats; Rats, Wistar; Sensation Disorders; Stereotyped Behavior

1997
GABA receptor agonist promotes reformation of the striatonigral pathway by transplant derived from fetal striatal primordia in the lesioned striatum.
    Experimental neurology, 1997, Volume: 147, Issue:2

    Topics: Animals; Apomorphine; Brain Damage, Chronic; Brain Ischemia; Brain Tissue Transplantation; Cell Count; Chemotherapy, Adjuvant; Combined Modality Therapy; Corpus Striatum; Fetal Tissue Transplantation; GABA Agonists; Infusion Pumps, Implantable; Male; Muscimol; Nerve Degeneration; Neural Pathways; Neuroprotective Agents; Rats; Rats, Wistar; Receptors, GABA; Stereotyped Behavior; Substantia Nigra

1997
Delayed cyanide induced dystonia.
    Journal of neurology, neurosurgery, and psychiatry, 1992, Volume: 55, Issue:3

    Topics: Adolescent; Adult; Apomorphine; Atrophy; Brain Damage, Chronic; Cerebral Cortex; Dystonia; Electroencephalography; Follow-Up Studies; Humans; Levodopa; Male; Neurologic Examination; Potassium Cyanide; Putamen; Reaction Time

1992